Mandalam Ramkumar 4

What Happened
Mandalam Ramkumar, a director of Cryoport, sold 23,214 shares in an open-market transaction on 2026-06-08 at a weighted average price of $15.44, for proceeds of approximately $358,452. On 2026-06-05 he was also granted awards totaling 26,427 rights (10,350 restricted stock rights and 16,077 derivative awards) at $0.00 (no cash paid).

Key Details

• Sale: 23,214 shares on 2026-06-08; weighted average price $15.44; total reported proceeds $358,452. (Footnote: sale prices ranged $15.40–$15.48; seller can provide per-trade breakdown.)
• Awards: Two grants dated 2026-06-05 — 10,350 restricted stock rights and 16,077 derivative awards, reported at $0.00.
• Shares owned after the transaction: Not specified in the provided report.
• Vesting/other footnotes:
  • F1: The 10,350 restricted stock rights vest in full on June 5, 2027 and convert one-for-one to common stock upon vesting.
  • F3: The 16,077 derivative awards vest 1/12th on the 5th of each month for 12 months beginning July 5, 2026.
  • F2: Weighted-average sale price and price range disclosure; breakdown available on request.
• Filing timeliness: Form 4 filed 2026-06-08; the filing does not indicate a late report.

Context
The sale was an open-market disposal (S) and the awards are non-cash compensation/derivative grants (A). The restricted stock rights will convert to common shares only after vesting (F1); the derivative awards vest monthly over a year (F3). These award grants are acquisitions on paper but involve no cash outlay at grant. The filing is factual and does not state the insider’s motivation.